Evidence map›Paper›PMID 40045891›Full record

ArticleHaematologica2025

Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia.

Shengqin Cheng, Li Gao, Jun Lu, Yixin Hu, Yi Wang, Hailong He, Jie Li, Suxiang Liu, Feiyun Yang, Xiaofang Wu and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Shengqin ChengDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Li GaoDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Jun LuDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Yixin HuDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Yi WangDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Hailong HeDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Jie LiDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Suxiang LiuDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Feiyun YangDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Xiaofang WuDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Liyan FanDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Junjie FanDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000.
Yanhua YaoDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Yina SunDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Bohan LiDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Yongping ZhangDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Shuiyan WuDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000.
Cheng ChengDivision of Leukemia/Lymphoma, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Peifang XiaoDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000. Email:xpfdr@163.com.
Raul C RibeiroDivision of Leukemia/Lymphoma, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. Raul.Ribeiro@stjude.org.
Hu ShaoyanDepartment of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Center of Jiangsu Province, No. 92, Zhongnan Street, Suzhou, 215000, China; Pediatric Hematology and Oncology Key Laboratory of Higher Education Institutions in Jiangsu Province, Suzhou, 215000. hushaoyan@suda.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40045891
PMCPMC12399955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.